Madrigal Pharmaceuticals (MDGL) Stock Chart & Stock Price History → The #1 Crypto That You Don’t Own… Yet (From Crypto 101 Media) (Ad) Free MDGL Stock Alerts $247.42 +3.08 (+1.26%) (As of 12:54 PM ET) Add Compare Share Share ChartStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Madrigal Pharmaceuticals Stock Price Performance5 Day Performance+3.40%1 Month Performance+18.88%3 Month Performance-4.43%6 Month Performance+17.13%Year-To-Date Performance+5.45%1 Year Performance-8.11% Receive MDGL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Wealthpin ProThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it. MDGL Stock Chart for Monday, June, 10, 2024 MDGL Chart by TradingView Madrigal Pharmaceuticals Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/07/2024$241.35$244.34+1.24%$245.11$227.78467,557 shs$5.21 billion06/06/2024$235.97$241.35+2.28%$241.50$219.65636,455 shs$5.14 billion06/05/2024$244.35$235.97-3.43%$236.84$208.602.05 million shs$5.03 billion06/04/2024$245.49$244.35-0.46%$251.59$238.14899,204 shs$5.21 billion06/03/2024$236.16$245.49+3.95%$245.55$235.78328,289 shs$5.23 billion05/31/2024$225.49$236.16+4.73%$236.70$221.88348,317 shs$5.03 billion Get the Latest News and Ratings for MDGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 05/30/2024$222.51$225.49+1.34%$228.88$223.72234,436 shs$4.81 billion05/29/2024$223.29$222.51-0.35%$224.55$219.39263,543 shs$4.74 billion05/28/2024$229.58$223.29-2.74%$233.55$222.72808,162 shs$4.76 billion05/27/2024$229.58$229.58$235.28$228.63374,400 shs$4.89 billion05/24/2024$234.85$229.58-2.24%$235.28$228.63374,471 shs$4.89 billion05/23/2024$235.06$234.85-0.09%$239.03$226.78446,983 shs$5.00 billion05/22/2024$242.49$235.06-3.06%$250.34$232.40817,821 shs$5.01 billion05/21/2024$232.10$242.49+4.48%$243.50$226.36402,452 shs$5.17 billion05/20/2024$220.06$232.10+5.47%$232.39$218.90313,493 shs$4.95 billion05/17/2024$217.17$220.06+1.33%$221.52$215.02236,438 shs$4.69 billion05/16/2024$211.73$217.17+2.57%$217.68$210.81235,180 shs$4.63 billion05/15/2024$210.98$211.73+0.36%$219.62$210.05392,482 shs$4.51 billion05/14/2024$211.32$210.98-0.16%$219.76$209.84262,278 shs$4.50 billion05/13/2024$205.25$211.32+2.96%$217.04$205.99269,883 shs$4.50 billion05/10/2024$206.92$205.25-0.81%$208.74$204.08234,030 shs$4.37 billion05/09/2024$208.04$206.92-0.54%$209.89$200.08359,421 shs$4.40 billion05/08/2024$217.96$208.04-4.55%$215.00$201.50690,489 shs$4.43 billion05/07/2024$235.57$217.96-7.48%$230.49$214.96780,368 shs$4.64 billion05/06/2024$229.84$235.57+2.49%$236.65$228.48423,450 shs$5.01 billion05/03/2024$216.05$229.84+6.38%$234.47$221.25441,612 shs$4.89 billion05/02/2024$210.59$216.05+2.59%$218.19$208.77451,678 shs$4.60 billion05/01/2024$204.02$210.59+3.22%$217.72$202.20427,524 shs$4.19 billion04/30/2024$201.07$204.02+1.47%$209.43$199.40435,464 shs$4.06 billion04/29/2024$193.33$201.07+4.00%$202.02$191.18357,096 shs$4.00 billion04/26/2024$194.38$193.33-0.54%$195.58$189.00453,241 shs$3.85 billion04/25/2024$204.65$194.38-5.02%$200.63$190.22707,187 shs$3.87 billion04/24/2024$218.38$204.65-6.29%$219.99$204.16575,483 shs$4.07 billion04/23/2024$213.49$218.38+2.29%$225.66$210.10409,532 shs$4.35 billion04/22/2024$212.04$213.49+0.68%$217.14$197.86726,664 shs$4.25 billion04/19/2024$222.26$212.04-4.60%$224.68$206.03624,815 shs$4.22 billion04/18/2024$228.34$222.26-2.66%$227.31$220.74268,850 shs$4.42 billion04/17/2024$232.98$228.34-1.99%$235.91$224.39251,038 shs$4.54 billion04/16/2024$231.37$232.98+0.70%$235.92$222.90343,867 shs$4.64 billion04/15/2024$236.59$231.37-2.21%$242.82$229.01322,867 shs$4.60 billionThe Only Energy Play You Should Be Looking At (Ad)Open AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has already inked deals with the Department of Energy.Click here to get all the information about it.04/12/2024$245.27$236.59-3.54%$245.36$236.49294,850 shs$4.71 billion04/11/2024$244.67$245.27+0.25%$248.63$243.25212,540 shs$4.88 billion04/10/2024$249.34$244.67-1.87%$246.23$241.48226,258 shs$4.87 billion04/09/2024$248.64$249.34+0.28%$253.17$244.02226,947 shs$4.96 billion04/08/2024$243.04$248.64+2.30%$248.82$242.20238,450 shs$4.95 billion04/05/2024$241.46$243.04+0.65%$246.34$238.27295,908 shs$4.84 billion04/04/2024$245.23$241.46-1.54%$248.42$240.33385,216 shs$4.81 billion04/03/2024$244.50$245.23+0.30%$247.33$241.13490,313 shs$4.88 billion04/02/2024$255.74$244.50-4.40%$250.94$241.52593,301 shs$4.87 billion04/01/2024$267.04$255.74-4.23%$267.25$255.00546,968 shs$5.09 billion03/29/2024$267.04$267.04$268.22$254.75441,995 shs$5.31 billion03/28/2024$258.81$267.04+3.18%$268.22$254.87441,791 shs$5.31 billion03/27/2024$247.62$258.81+4.52%$259.53$244.85442,701 shs$5.15 billion03/26/2024$247.62$247.62$251.99$246.61234,085 shs$4.93 billion03/25/2024$248.20$247.62-0.23%$257.48$246.54394,413 shs$4.93 billion03/22/2024$255.27$248.20-2.77%$258.52$242.38529,937 shs$4.94 billion03/21/2024$258.99$255.27-1.44%$265.79$251.79376,212 shs$5.08 billion03/20/2024$265.68$258.99-2.52%$267.00$251.51674,651 shs$5.15 billion03/19/2024$283.23$265.68-6.20%$276.67$263.51915,038 shs$5.29 billion03/18/2024$270.37$283.23+4.76%$292.86$272.01963,934 shs$5.64 billion03/15/2024$243.57$270.37+11.00%$299.98$262.002.77 million shs$5.38 billion03/14/2024$272.98$243.57-10.77%$276.30$236.621.31 million shs$4.85 billion03/13/2024$262.67$272.98+3.93%$275.02$265.01765,507 shs$5.43 billion03/12/2024$260.15$262.67+0.97%$269.68$258.08596,475 shs$5.23 billion03/11/2024$255.32$260.15+1.89%$266.83$253.00678,833 shs$5.08 billion Related Companies: Rocket Pharmaceuticals Stock Chart Y-mAbs Therapeutics Stock Chart Generation Bio Stock Chart Alnylam Pharmaceuticals Stock Chart BioMarin Pharmaceutical Stock Chart Neurocrine Biosciences Stock Chart Incyte Stock Chart United Therapeutics Stock Chart Repligen Stock Chart Exact Sciences Stock Chart Receive MDGL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MDGL) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredBiden out June 13; replacement chosen?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in...Paradigm Press | Sponsored[PDF Inside] Crypto's $1 Trillion 60-Day Boom + New 2024 Profit StrategyThe crypto industry is exploding and Chris Munch just released a new PDF detailing how you can potentially pro...DeFi Distribution | SponsoredTrump convicted... now what?Unexpected Twist to Trump's Trial Most folks sense there's more to the Trump trial than meets the eye. B...Stansberry Research | SponsoredIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.